Edward Raymond

Array ( [id] => 11575942 [patent_doc_number] => 09631190 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'Cell attachment coatings and methods using phosphorous-containing photoreagent' [patent_app_type] => utility [patent_app_number] => 13/930512 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11394 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13930512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10317247 [patent_doc_number] => 20150202250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'ANTICANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/408780 [patent_app_country] => US [patent_app_date] => 2013-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 29131 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10202605 [patent_doc_number] => 20150087593 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'COAGULATION FACTOR VIII WITH REDUCED IMMUNOGENICITY' [patent_app_type] => utility [patent_app_number] => 14/402922 [patent_app_country] => US [patent_app_date] => 2013-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8828 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9691246 [patent_doc_number] => 08821836 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'SPARC binding peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/896973 [patent_app_country] => US [patent_app_date] => 2013-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15643 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13896973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11574698 [patent_doc_number] => 09629939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'Collagenous foam materials' [patent_app_type] => utility [patent_app_number] => 14/403396 [patent_app_country] => US [patent_app_date] => 2013-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5283 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10256331 [patent_doc_number] => 20150141329 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2015-05-21 [patent_title] => 'NEURTURIN MOLECULES' [patent_app_type] => utility [patent_app_number] => 13/846281 [patent_app_country] => US [patent_app_date] => 2013-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29974 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13846281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10256331 [patent_doc_number] => 20150141329 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2015-05-21 [patent_title] => 'NEURTURIN MOLECULES' [patent_app_type] => utility [patent_app_number] => 13/846281 [patent_app_country] => US [patent_app_date] => 2013-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 29974 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13846281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9844247 [patent_doc_number] => 08946163 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Cross-linked collagen comprising metallic anticancer agents' [patent_app_type] => utility [patent_app_number] => 13/815834 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15454 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13815834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10202601 [patent_doc_number] => 20150087590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'DIASPIRIN CROSSLINKED PEGYLATED HEMOGLOBIN' [patent_app_type] => utility [patent_app_number] => 14/388956 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10633 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14388956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9735831 [patent_doc_number] => 20140271544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'COMBINATION THERAPY FOR TREATING HCV INFECTION IN SPECIFIC PATIENT SUBGENOTYPE SUB-POPULATION' [patent_app_type] => utility [patent_app_number] => 13/799133 [patent_app_country] => US [patent_app_date] => 2013-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8494 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13799133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8990351 [patent_doc_number] => 20130217632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'Non-Natural Amino Acids' [patent_app_type] => utility [patent_app_number] => 13/784212 [patent_app_country] => US [patent_app_date] => 2013-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 29614 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13784212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9016503 [patent_doc_number] => 20130231467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'METHOD AND SYSTEM FOR SOLUBILIZING PROTEIN' [patent_app_type] => utility [patent_app_number] => 13/771688 [patent_app_country] => US [patent_app_date] => 2013-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 40112 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13771688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10669647 [patent_doc_number] => 20160015793 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-21 [patent_title] => 'MODULATION OF FACTOR XA INHIBITOR MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE' [patent_app_type] => utility [patent_app_number] => 14/378440 [patent_app_country] => US [patent_app_date] => 2013-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 18229 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14378440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950017 [patent_doc_number] => 20130195797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'HIGH POTENCY FORMULATIONS OF VX-950' [patent_app_type] => utility [patent_app_number] => 13/754365 [patent_app_country] => US [patent_app_date] => 2013-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15185 [patent_no_of_claims] => 114 [patent_no_of_ind_claims] => 45 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13754365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823532 [patent_doc_number] => 08933016 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Metallodrugs having improved pharmacological properties and methods of manufacture and use thereof' [patent_app_type] => utility [patent_app_number] => 13/745359 [patent_app_country] => US [patent_app_date] => 2013-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 16692 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13745359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8904745 [patent_doc_number] => 20130172248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => '3-[4-(PHENYLAMINOOXALYLAMINO)PHENYL]HEX-4-YNOIC ACIDS, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS A MEDICAMENT' [patent_app_type] => utility [patent_app_number] => 13/734413 [patent_app_country] => US [patent_app_date] => 2013-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17901 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13734413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8904768 [patent_doc_number] => 20130172271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'Pharmaceutical Spray Drying' [patent_app_type] => utility [patent_app_number] => 13/734329 [patent_app_country] => US [patent_app_date] => 2013-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6385 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13734329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10634563 [patent_doc_number] => 09352050 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-31 [patent_title] => 'Processes for preparing peptide conjugates and linkers' [patent_app_type] => utility [patent_app_number] => 14/367216 [patent_app_country] => US [patent_app_date] => 2012-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24813 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14367216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8884073 [patent_doc_number] => 20130157257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'Compositions Comprising the NC2 Domain of Collagen IX and Methods of Using Same' [patent_app_type] => utility [patent_app_number] => 13/684310 [patent_app_country] => US [patent_app_date] => 2012-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14909 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13684310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10919177 [patent_doc_number] => 20140322196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'LACTOFERRIN DERIVED PEPTIDES FOR USE AS BROAD-SPECTRUM INHIBITORS OF INFLUENZA VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 14/358713 [patent_app_country] => US [patent_app_date] => 2012-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11352 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358713 [rel_patent_id] =>[rel_patent_doc_number] =>)